Drug Search Results

Nastorazepide

Alternative Names: nastorazepide, z-360
Latest Update: 2024-01-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: CCK Inhibitor

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Intravenous,Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Zeria Co
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Nastorazepide

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Pancreatic Cancer|Adenocarcinoma

Phase 1: Healthy Volunteers

Trial	Phase	Trial Status	Disease	Primary Completion Date
ZIPANG	P2	Completed	Pancreatic Cancer\|Adenocarcinoma	2016-07-01
01A10101	P1	Completed	Healthy Volunteers	2013-04-01
01010106E	P2	Completed	Pancreatic Cancer	2007-12-01
2005-001659-39	P2	Completed	Pancreatic Cancer	2007-02-07

Recent News Events

Date	Type	Title
01/01/2024	PubMed	Improved quantitative determination of (R)- and (S)-rabeprazole sodium and its metabolites in rat plasma by LC-MS/MS and its application to a toxicokinetic study.
07/12/2022	PubMed	Development and Validation of Chemometrics-Assisted Green UPLC-MS/MS Bioanalytical Method for Simultaneous Estimation of Capecitabine and Lapatinib in Rat Plasma.
02/09/2021	PubMed	Preliminary Study of a 1,5-Benzodiazepine-Derivative Labelled with Indium-111 for CCK-2 Receptor Targeting.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions